Mustafa MJA, Mohamed MB, Hayat A. Tumour Lysis Syndrome and Partial Remission Occurring After Administration of a Test Dose of Obinutuzumab. EJCRIM [Internet]. 2017 Jan. 27 [cited 2026 Nov. 4];4(1). Available from: https://ejcrim.com/index.php/ejcrim/article/view/516